Concepedia

Olugbeminiyi Fadeyi

OF

40

Publications

3.1K

Citations

25

H-Index

2008

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Pfizer (United States)

Vanderbilt University

Princeton University

United States Military Academy

Olugbeminiyi Fadeyi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, natural sciences, and photochemistry.

ORCID

Top concepts

Publications per year

2008–2024

40

Publications

40

Microenvironment mapping via Dexter energy transfer on immune cells

Jacob B. Geri, James V. Oakley, Tamara Reyes Robles et al. · Science · 2020 · 422 citations · Full text

, , +23

Mediator kinase inhibition further activates super-enhancer-associated genes in AML

Henry E. Pelish, Brian B. Liau, I Niţulescu et al. · Nature · 2015 · 391 citations · Full text

, , +5

Strain-Release Heteroatom Functionalization: Development, Scope, and Stereospecificity

Justin M. Lopchuk, Kasper Fjelbye, Yu Kawamata et al. · Journal of the American Chemical Society · 2017 · 326 citations · Full text

Modular radical cross-coupling with sulfones enables access to sp <sup>3</sup> -rich (fluoro)alkylated scaffolds

Rohan R. Merchant, Jacob T. Edwards, Tian Qin et al. · Science · 2018 · 211 citations

Visible‐Light‐Initiated Manganese Catalysis for C−H Alkylation of Heteroarenes: Applications and Mechanistic Studies

Philippe Nuhant, Martins S. Oderinde, Julien Genovino et al. · Angewandte Chemie International Edition · 2017 · 182 citations

Rows per page

1–5 of 40